AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Robert A. Michael
CEORobert A. Michael
Employees
55,000
Employees55,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
55,000
Employees55,000

ABBV Key Statistics

Market cap
339.75B
Market cap339.75B
Price-Earnings ratio
83.15
Price-Earnings ratio83.15
Dividend yield
3.27%
Dividend yield3.27%
Average volume
8.48M
Average volume8.48M
High today
$194.50
High today$194.50
Low today
$191.18
Low today$191.18
Open price
$193.68
Open price$193.68
Volume
4.99M
Volume4.99M
52 Week high
$218.66
52 Week high$218.66
52 Week low
$163.81
52 Week low$163.81

ABBV News

Seeking Alpha 21h
Dividend Roundup: CVS Health, Procter & Gamble, AbbVie, Colgate-Palmolive, and more

This week's dividend activity included increased payouts from PB Financial (OTCQX:PBNC) and Ryder (R) as well as declarations from companies such as CVS Health...

Dividend Roundup: CVS Health, Procter & Gamble, AbbVie, Colgate-Palmolive, and more
Simply Wall St 22h
Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. For Its Upcoming Dividend

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see AbbVie Inc. ( ) is about to trade ex-dividend in the n...

Dividend Investors: Don't Be Too Quick To Buy AbbVie Inc. For Its Upcoming Dividend
Benzinga 2d
Why Is AbbVie Stock Trading Higher On Thursday?

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation Inc., and AbbVie Inc. ABBV, on Thursday, announced an exclusive lice...

Why Is AbbVie Stock Trading Higher On Thursday?

Analyst ratings

60%

of 30 ratings
Buy
60%
Hold
40%
Sell
0%

More ABBV News

TipRanks 2d
AbbVie’s SELECT-SLE Study: A Promising Step in Lupus Treatment

Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks P...

Seeking Alpha 2d
AbbVie and Ichnos Glenmark sign licensing deal for ISB 2001

AbbVie (NYSE:ABBV) and IGI Therapeutics SA, a unit of Ichnos Glenmark Innovation, entered into a licensing agreement for IGI's lead research drug, ISB 2001, aim...

AbbVie and Ichnos Glenmark sign licensing deal for ISB 2001
TipRanks 2d
AbbVie: A Strong Buy with Promising Growth Prospects and Stable Outlook

Analyst Chris Schott of J.P. Morgan maintained a Buy rating on AbbVie, with a price target of $200.00. Don’t Miss TipRanks’ Half-Year Sale Take advantage of T...

TipRanks 4d
Pfizer and AbbVie Advance Pediatric Infection Study with ATM-AVI

Pfizer Inc ((PFE)), Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Take adv...

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.